Orexo AB Financials

Orexo AB Stock Summary

Orexo AB competes with Genomma Lab, Hypera SA, Elanco Animal, SIGA Technologies, and Esperion Therapeutics. Orexo AB , a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, Europe, and the United Kingdom. Orexo AB was incorporated in 1994 and is headquartered in Uppsala, Sweden. Orexo Ab is traded on OTC Exchange in the United States.

Orexo AB Key Financial Ratios

There are many critical financial ratios that Orexo AB's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Orexo AB reports annually and quarterly.

Orexo Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Orexo AB's current stock value. Our valuation model uses many indicators to compare Orexo AB value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Orexo AB competition to find correlations between indicators driving Orexo AB's intrinsic value. More Info.Orexo AB is rated below average in return on equity category among its peers. It also is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Orexo AB's earnings, one of the primary drivers of an investment's value.

Orexo AB Market Pulse

Along with financial statement analysis, the daily predictive indicators of Orexo AB help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Orexo AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Orexo AB based on widely used predictive technical indicators. In general, we focus on analyzing Orexo OTC Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Orexo AB's daily price indicators and compare them against related drivers.

When running Orexo AB's price analysis, check to measure Orexo AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Orexo AB is operating at the current time. Most of Orexo AB's value examination focuses on studying past and present price action to predict the probability of Orexo AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Orexo AB's price. Additionally, you may evaluate how the addition of Orexo AB to your portfolios can decrease your overall portfolio volatility.